v3.25.2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
ASSETS    
Cash and cash equivalents $ 2,910 $ 1,443
Prepaid expenses and other current assets 1,680 1,859
Total current assets 4,590 3,302
Other assets 248 349
Total assets 4,838 3,651
LIABILITIES AND STOCKHOLDERS’ DEFICIT    
Accounts payable 3,630 4,130
Accrued and other current liabilities 9,974 10,149
Accrued clinical site costs 351 379
Convertible note payable and accrued interest – short term 9,854 1,246
Insurance loan payable 378 320
Warrant liabilities 16,266 5,639
Total current liabilities 40,453 21,863
Convertible note payable and accrued interest – long term 0 5,011
Total liabilities 40,453 26,874
Commitments and Contingencies (Note 8)
Common stock, $0.001 par value, 500,000,000 shares authorized; 19,473,588 and 14,591,505 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 19 15
Additional paid-in capital 265,732 255,035
Accumulated deficit (301,366) (278,273)
Total stockholders’ deficit (35,615) (23,223)
Total liabilities and stockholders' deficit 4,838 3,651
Nondesignated Preferred Stock [Member]    
LIABILITIES AND STOCKHOLDERS’ DEFICIT    
Preferred stock 0 0
Series A Convertible Preferred Stock [Member]    
LIABILITIES AND STOCKHOLDERS’ DEFICIT    
Preferred stock $ 0 $ 0